International Psoriasis Council

Advancing Knowledge. Improving Care.

Christopher

Griffiths

,

OBE, MD, FMedSci

Emeritus Professor of Dermatology and an Adjunct Professor
University of Manchester and King’s College London
London
,
United Kingdom
IPC Honorary Founder
Professor Chris Griffiths is an Emeritus Professor of Dermatology at the University of Manchester and an Adjunct Professor at King’s College London. He founded the Manchester Dermatopharmacology Unit and the Manchester Psoriasis Service in 1994 and has received many awards for his work, including OBE “for services to dermatology” in the 2018 Queen’s New Year’s Honours. Chris is a former President of the European Society for Dermatological Research (ESDR), the British Association of Dermatologists (BAD), and the International Psoriasis Council (IPC), which he co-founded in 2004. He is Editor-in-Chief of Rook’s Textbook of Dermatology and Rook’s Dermatology Handbook and is the third most cited dermatologist in the world. Chris has a career-long interest in all aspects of psoriasis and was part of the team that showed psoriasis to be an immune-mediated disease. He is active in global health initiatives, including directing the Global Psoriasis Atlas (GPA) and co-founding the Burma Skincare Initiative (BSI) charity.
Last Updated:
03/04/2026

Areas of Interest

Global Psoriasis Atlas, stratified medicine, advanced therapeutics and global health research and policy.

IPC Committees / Groups

Diverse Skin Types Working Group, Global Psoriasis Atlas, Honorary Founding

Languages Spoken

English

Involvement with Other Organization(s)

Involved with the International Federation of Psoriasis Associations (IFPA), the Psoriasis Association of the United Kingdom, and the National Psoriasis Foundation (NPF).

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026